Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (13)
  • (-) Currently Recruiting (1)
  • Closed (12)

Medical Condition

  • Show all (235)
  • Addiction (5)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (12)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (6)
  • Ear, Nose and Throat (7)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (3)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (44)
  • Heart Disease (20)
  • Infectious Disease (11)
  • Liver Disease (13)
  • Lung Disease (2)
  • Neurological Disorders (31)
  • Nutrition (1)
  • Obesity (9)
  • Obstetrics & Gynecology (10)
  • Pediatrics (17)
    • Cancer (2)
    • Child and Adolescent Health (2)
    • (-) Neuromuscular (0)
  • Psychiatric Disorders (9)
  • Rehabilitation (2)
  • Stroke (2)
  • Transplant (12)
    • (-) Kidney Transplant (1)
    • Liver Transplant (9)
  • Vascular Conditions (1)
Displaying 1 - 1 of 1

VEL-101 (VELOXIS) to Prevent Rejection After Kidney Transplantation

Condition: Transplant / Kidney Transplant
Investigator: Lloyd Ratner, MD, MPH, FACS
Status: Currently Recruiting
The main goal of this clinical trial is to determine if an investigational medication called VEL101 is safe, well tolerated, and effective in people receiving a new kidney transplant. Participants will be randomly assigned to 2 different doses of VEL-101 or to tacrolimus, which is standardly used post-transplant to prevent rejection. Participants will be…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science